A First-in-Class, Non-Azole, Fungicidal Treatment for Women with Vulvovaginal Candidiasis
Description: This webinar will explore the unmet needs of VVC, VVC epidemiology, and burden and provide a clinical overview of BREXAFEMME. Please click here for additional information.
Following this webinar attendees will have a full understanding of:
- The prevalence of VVC, epidemiology, clinical symptoms, associated economic burden and broad range of VVC patients that are under served:
- Brexafemme clinical overview, fungicidal mechanism of action, adverse event profile, dosing and administration.
Target Audience: Providers: obstetrician-gynecologists, advanced registered nurse practitioners, physician assistants, midwives, primary care physicians
Speaker and Presenter Information
Peter A. Khamvongsa, MD, Associate Professor, Division of Obstetrics and Gynecology, Florida International University College of Medicine, President and Chief Medical Officer, Department of Urogynecology and Minimally Invasive Surgery
Miami Institute for Women’s Health, Miami, FL
Relevant Government Agencies
Air Force, Army, DOD & Military, Dept of Health & Human Services, Dept of Homeland Security, Dept of Veterans Affairs, Coast Guard, Census Bureau
Event Type
Webcast
This event has no exhibitor/sponsor opportunities
When
Thu, Jun 16, 2022, 12:00pm - 1:00pm
ET
Cost
Complimentary: $ 0.00
Website
Click here to visit event website
Organizer
AMSUS
